Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Applicability of Whole Genome Sequencing for Human Blood Group Genotyping and Genetic Definition of New Alleles as Exemplified on References and the Two MNSs-variants: U- and Stones(a)+

NCT02534519 is registered in ClinicalTrials.gov with Blood Donation Service Zurich, SRC as lead sponsor.

NCT NCT02534519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02534519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Applicability of Whole Genome Sequencing for Human Blood Group Genotyping and Genetic Definition of New Alleles as Exemplified on References and the Two MNSs-variants: U- and Stones(a)+
Lead sponsor
Blood Donation Service Zurich, SRC
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2015
Completion date
June 30, 2018
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic blood group (bg) polymorphism in u negativity and st(a) of mnss